Liquidia (LQDA) Research & Development (2020 - 2026)

Liquidia's (LQDA) quarterly Research & Development came in at $12.6 million in Q1 2026, up 80.46% year-on-year from $7.0 million in Q1 2025, and down 25.8% quarter-over-quarter from $16.9 million in Q4 2025.

Liquidia (LQDA) Research & Development (2020 - 2026) Analysis & Trends

Liquidia's Research & Development history runs 7 years deep, the most recent figure standing at $12.6 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 80.46% year-over-year to $12.6 million in Q1 2026; TTM through Mar 2026 was $44.9 million, a 0.29% change from a year earlier, with the FY2025 full-year figure at $39.3 million, down 17.9% from the prior year.
  • Research & Development eased to $12.6 million in Q1 2026 per LQDA's latest filing, from $16.9 million in the prior quarter.
  • Across five years, Research & Development topped out at $17.7 million in Q2 2023 and bottomed at $4.5 million in Q3 2022.
  • The 5-year median for Research & Development is $9.3 million (2025), against an average of $9.6 million.
  • Across the five-year window, Research & Development surged 239.05% in 2023 and sank 46.76% in 2024, its largest moves.
  • Year by year, Research & Development stood at $5.0 million in 2022, then soared by 157.82% to $12.8 million in 2023, then gained by 28.42% to $16.5 million in 2024, then gained by 2.84% to $16.9 million in 2025, then retreated by 25.8% to $12.6 million in 2026.
  • Per Business Quant, the three latest LQDA Research & Development figures stand at $12.6 million (Q1 2026), $16.9 million (Q4 2025), and $9.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 696.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 180.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 7.37 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 138.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 248.60 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 296.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 97.00 Mn
10 Liquidia 7.84 Bn 7.61 Bn 121.79 Mn 12.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.57 Mn
Dec 31, 2025 16.94 Mn
Sep 30, 2025 9.35 Mn
Jun 30, 2025 6.02 Mn
Mar 31, 2025 6.97 Mn
Dec 31, 2024 16.48 Mn
Sep 30, 2024 11.89 Mn
Jun 30, 2024 9.42 Mn
Mar 31, 2024 10.06 Mn
Dec 31, 2023 12.83 Mn
Sep 30, 2023 7.44 Mn
Jun 30, 2023 17.70 Mn
Mar 31, 2023 5.28 Mn
Dec 31, 2022 4.98 Mn
Sep 30, 2022 4.51 Mn
Jun 30, 2022 5.22 Mn
Mar 31, 2022 4.73 Mn
Dec 31, 2021 5.38 Mn
Sep 30, 2021 4.49 Mn
Jun 30, 2021 4.60 Mn